DAIICHI SANKYO COMPANY, LIMITED
4568・Prime Market・Pharmaceuticals
DAIICHI SANKYO COMPANY, LIMITED4568
Recent Disclosures
| Date | Type | Title |
|---|---|---|
| 2026-07-16 | Other | Daiichi Sankyo Announces Completion of Payment Concerning Disposal of Own Shares as Restricted Share-Based Compensation |
| 2026-07-16 | Other | 譲渡制限付株式報酬としての自己株式の処分の払込完了に関するお知らせ |
| 2026-07-03 | Other | 訂正有価証券報告書-第21期(2025/04/01-2026/03/31) |
| 2026-06-30 | Other | Daiichi Sankyo Announces Disposal of Own Shares as Medium-Term Performance-Based Share Compensation for Company’s Directors and Corporate Officers |
| 2026-06-30 | Other | 当社取締役等に対する中計業績連動株式報酬としての自己株式の処分に関するお知らせ |
| 2026-06-23 | Other | Daiichi Sankyo Corporate Governance Report |
| 2026-06-23 | Other | コーポレート・ガバナンスに関する報告書 2026/06/23 |
| 2026-06-22 | Other | 譲渡制限付株式報酬としての自己株式の処分に関するお知らせ |
| 2026-06-22 | Other | Daiichi Sankyo Announces Disposal of Own Shares as Restricted Share-Based Compensation |
| 2026-06-19 | Other | 有価証券報告書-第21期(2025/04/01-2026/03/31) |

